Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 92, Issue 20, Pages -
Publisher
American Society for Microbiology
Online
2018-08-01
DOI
10.1128/jvi.00969-18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection
- (2017) Ajitanuj Rattan et al. PLoS Pathogens
- Complement Evasion Strategies of Viruses: An Overview
- (2017) Palak Agrawal et al. Frontiers in Microbiology
- Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice
- (2017) Yu-Jin Kim et al. Frontiers in Immunology
- A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus
- (2016) Yu-Na Lee et al. JOURNAL OF IMMUNOLOGY
- Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine
- (2016) Eun-Ju Ko et al. JOURNAL OF IMMUNOLOGY
- Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines
- (2015) Yu-Na Lee et al. Immune Network
- Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination
- (2014) Yu-Na Lee et al. IMMUNOLOGY
- Roles of Major Histocompatibility Complex Class II in Inducing Protective Immune Responses to Influenza Vaccination
- (2014) Eunju O et al. JOURNAL OF VIROLOGY
- Supplementation of Influenza Split Vaccines with Conserved M2 Ectodomains Overcomes Strain Specificity and Provides Long-term Cross Protection
- (2014) Min-Chul Kim et al. MOLECULAR THERAPY
- In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen
- (2014) Teddy Wohlbold et al. Viruses-Basel
- New World Bats Harbor Diverse Influenza A Viruses
- (2013) Suxiang Tong et al. PLoS Pathogens
- Complement Mediated Signaling on Pulmonary CD103+ Dendritic Cells Is Critical for Their Migratory Function in Response to Influenza Infection
- (2013) Matheswaran Kandasamy et al. PLoS Pathogens
- Virus-like particles as universal influenza vaccines
- (2012) Sang-Moo Kang et al. Expert Review of Vaccines
- Regulation of Humoral Immunity by Complement
- (2012) Michael C. Carroll et al. IMMUNITY
- Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus
- (2012) Min-Chul Kim et al. MOLECULAR THERAPY
- Proteomic Characterization of Influenza H5N1 Virus-like Particles and Their Protective Immunogenicity
- (2011) Jae-Min Song et al. JOURNAL OF PROTEOME RESEARCH
- A Protective Role for Complement C3 Protein during Pandemic 2009 H1N1 and H5N1 Influenza A Virus Infection
- (2011) Kevin B. O'Brien et al. PLoS One
- Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
- (2011) Jae-Min Song et al. PLoS One
- Structures of influenza A proteins and insights into antiviral drug targets
- (2010) Kalyan Das et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles
- (2010) Jae-Min Song et al. VIROLOGY
- Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein
- (2008) R WANG et al. ANTIVIRAL RESEARCH
- CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine
- (2008) Dubravka Grdic Eliasson et al. VACCINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started